Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Mesoblast Limited (MSB)
  6. Company Announcements

Mesoblast Limited (ASX: MSB) - Announcements

Current share price for MSB : $1.025 0.025 (2.38%)

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Mesoblast Limited (MSB)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$1,170 Change in substantial holding 3 Aug 2023 8:18AM $1.090 $1.025 $1.130 fallen by 5.96%
$1,170 Trading Halt 2 Aug 2023 8:41AM $1.090 $1.025 $1.130 fallen by 5.96%
$1,170 Change in substantial holding 1 Aug 2023 8:12AM $1.145 $1.025 $1.130 fallen by 10.48%
$1,170 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2023 9:49AM $1.150 $1.025 $1.130 fallen by 10.87%
$1,170 Appendix 3G, Appendix 3H and Appendix 3Ys 7 Jul 2023 5:22PM $1.130 $1.025 $1.130 fallen by 9.29%
$1,170 Change of Director's Interest Notice 13 Jun 2023 8:56AM $1.025 $1.025 $1.130 fallen by 0%
$1,170 Mesoblast Director Appointed to Strategic Advisory Role 5 Jun 2023 9:41AM $1.065 $1.025 $1.130 fallen by 3.76%
$1,170 MSB Reports Q3 Financial Results and Operational Highlights 26 May 2023 8:32AM $1.040 $1.025 $1.130 fallen by 1.44%
$1,170 Third Quarter Results Presentation 26 May 2023 8:26AM $1.040 $1.025 $1.130 fallen by 1.44%
$1,170 Third Quarter Financial Results on Form 6-K 26 May 2023 8:21AM $1.040 $1.025 $1.130 fallen by 1.44%
$1,170 Mesoblast Third Quarter Financial Results Webcast 24 May 2023 6:02PM $1.055 $1.025 $1.130 fallen by 2.84%
$1,170 Becoming a substantial holder 3 May 2023 9:16AM $0.890 $1.025 $1.130 risen by 15.17%
$1,170 Change in substantial holding 3 May 2023 8:16AM $0.890 $1.025 $1.130 risen by 15.17%
$1,170 Cleansing Notice 1 May 2023 5:23PM $0.870 $1.025 $1.130 risen by 17.82%
$1,170 Application for quotation of securities - MSB 28 Apr 2023 4:38PM $0.860 $1.025 $1.130 risen by 19.19%
$1,170 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 10:24AM $0.883 $1.025 $1.130 risen by 16.15%
$1,170 Reinstatement to Official Quotation 26 Apr 2023 9:54AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 Proposed issue of securities - MSB 26 Apr 2023 9:54AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 Mesoblast Completes Private Placement 26 Apr 2023 9:54AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 Voluntary Suspension 24 Apr 2023 9:23AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 Trading Halt 20 Apr 2023 10:59AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 Pause in Trading 20 Apr 2023 10:31AM $0.990 $1.025 $1.130 risen by 3.54%
$1,170 FDA Schedules GvHD Pre-License Manufacturing Inspection 22 Mar 2023 11:08AM $0.900 $1.025 $1.130 risen by 13.89%
$1,170 Appendix 3G and Appendix 3H 15 Mar 2023 6:42PM $0.960 $1.025 $1.130 risen by 6.77%
$1,170 FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L 8 Mar 2023 10:35AM $0.925 $1.025 $1.130 risen by 10.81%

76 - 100 of 911 results

Page 4 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.